Abstract
The ablative radioiodine therapy of differentiated thyroid carcinoma Abstract. In the treatment of differentiated thyroid carcinoma, ablative radioiodine therapy holds a key role in curative intended therapy after total thyroidectomy and consideration of the appropriate indication. The benefit of ablation therapy extends from the completion of initial staging via post-therapeutic whole body scintigraphy via optimization of the value of thyreoglobuline measurement and implementation of dynamic risk stratification in follow-up care to decreasing the rate of tumor recurrence and mortality of thyroid cancer. Within this article, we discuss aims, indication, side reactions and specifics in preparation and execution of ablative radioiodine therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
